CHF trial mythbusting, page-2

  1. 8,095 Posts.
    lightbulb Created with Sketch. 45
    @hottuna,

    I understand what you are saying - not saying I agree, I have n.f.i to be honest. The only suggestion I have is that Mesoblast be asked directly and unambiguously whether or not they (and Teva) received the binary yes/no from the statistician, and, if they did receive it, was it a yes or a no. If they have been told, how do you feel that reconciles with the FDA ruling that no trial data at all be released? Regardless of what the ceo said last month, how can they not be in conflict with this ruling if they have this result?


    Anyway, I have sent in an email, If I get an answer I will share it.
    Last edited by aatisket: 20/06/16
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.84
Change
0.185(11.2%)
Mkt cap ! $2.351B
Open High Low Value Volume
$1.66 $1.84 $1.65 $13.70M 7.781M

Buyers (Bids)

No. Vol. Price($)
1 10000 $1.84
 

Sellers (Offers)

Price($) Vol. No.
$1.84 33618 8
View Market Depth
Last trade - 16.19pm 01/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.